EYE

[eliteG]

EYE(nyse) - Advanced Medical Optics, Inc.

Mkt Cap:             3.42B
Float:                 68.46M

Profile:  Advanced Medical Optics is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom™, Phacoflex®, Clariflex®, Array®, Sensar®, CeeOn®, Tecnis® and Verisyse™ intraocular lenses, STAR S4 IR™ laser vision correction system, WaveScan Wavefront® System, CustomVue™ procedure, Sovereign® and Sovereign® Compact™ phacoemulsification systems with WhiteStar® technology, Amadeus™ and Amadeus™ II microkeratomes, Healon® and Vitrax® viscoelastics, and the Baerveldt® glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE® Moisture PLUS™, COMPLETE® Blink-N-Clean®, Consept®F, Consept® 1 Step, Oxysept® 1 Step, UltraCare®, Ultrazyme®, Total Care™ and blinkTM branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,500 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.

Company Website[/url]


What makes this stock "On Fire"?

A technical breakout on volume after raising guidance.  A forward PE of around 20.

Advanced Medical Optics Reconfirms Revenue Guidance and Updates Adjusted EPS Guidance
Thursday June 8, 7:00 am ET
Increase to 2006-2007 Adjusted EPS Guidance Reflects Impacts of Recently Announced Convertible Note Offering, Share and Note Repurchase
http://biz.yahoo.com/prnews/060608/lath041.html?.v=58

Technicals
All-time high breakout on volume.. plenty of bullish momentum.

All History Chart  



----------------------------------------------------------------------

3-year weekly  


----------------------------------------------------------------------

7-month  



Trade Plan

Stocks making all-time highs have a lot of happy investors and are susceptible to nice rallies.  If our timing is correct we may get a nice run on this play. We are buying EYE at the highest its ever been.. and we'll sell it even higher.

We will buy EYE on Monday 6/26

[la-onda]

additional information:

1)
EYE: Wachovia Sets @ Mkt Perform; Analyst Notes
Friday , June 16, 2006 07:53 ET
Issuer: Advanced Medical Optics Incorporated (NYSE: EYE)
Analyst Firm:  Wachovia Securities Inc.
Current Rating: Mkt Perform
Analyst Comments: The firm is resuming coverage on the stock and is positive on EYE's long-term potential, but at its current valuation it does not offer an overly attractive risk/reward, hence the Market Perform rating. Their valuation range is $52-$55.

2)
EYE: Short Interest UP 13.2% to 10.8M in Jun 2006
Wednesday, June 21, 2006 17:17 ET

According to new short interest data from NYSE, short interest for Advanced Medical Optics Incorporated (NYSE: EYE) INCREASED 13.2% to 10,765,728 shares for the month ended mid-June, 2006.

SYMBOL               MAY            JUNE          CHANGE       %CHANGE    DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
EYE            9,509,719      10,765,728      +1,256,009       +13.21%           8

Based on EYE's 20-day average daily share volume of 1,511,085, it would require approximately 8 day(s) of buying to cover this short interest.

3)
EYE: Lehman Starts @ Overweight; Sets Tgt @ $60; Analyst Notes
Monday , June 12, 2006 08:14 ET
Issuer: Advanced Medical Optics Incorporated (NYSE: EYE)
Analyst Firm:  Lehman Brothers Holdings Inc.
Ratings Action: INITIATE
Current Rating: Overweight
Target Price Action: INITIATE
Target Price: $60.00
Analyst Comments: The firm is positive on EYE's new product pipeline & product rationalization efforts, positive industry outlook, and likely industry consolidation.

[eliteG]

update EYE:

We bought our position in EYE today.. and the chart looks great. 

------
Position: bought EYE @ 49.40 on 06/26/2006
Order: Hold
Exit: n/a
Target: n/a
------

[eliteG]

update EYE:

------
Position: bought EYE @ 49.40 on 06/26/2006
Order: Hold
Exit: stop @ 46.44
Target: n/a
------

[eliteG]

update EYE:

------
Position: bought EYE @ 49.40 on 06/26/2006
Order: Hold
Exit: stop @ 46.44
Target: n/a
------

[eliteG]

update EYE:

------
Position: bought EYE @ 49.40 on 06/26/2006
Order: Hold
Exit: stop @ 46.44
Target: n/a
------

[eliteG]

update EYE:

Breakout on volume.. lets move our stop higher 

------
Position: bought EYE @ 49.40 on 06/26/2006
Order: Hold
Exit: stop @ 48.75
Target: n/a
------

[eliteG]

update EYE:

Lets move our stop even higher.. no need to mess around. 

------
Position: bought EYE @ 49.40 on 06/26/2006
Order: Hold
Exit: stop @ 49.75
Target: n/a
------

[setravis]

Updated chart look.......